DOCTORS'
Medical Case Studies
cisplatin, cisplatin, adria, etoposide, platinum, carboplatin, taxol, cisplatin, etoposide, combination chemotherapy. ... cisplatin, cisplatin, adria, etoposide, platinum, carboplatin, taxol, cisplatin, etoposide, combination chemotherapy. ...
, Dr. G. recommended chemotherapy treatment as follows: Carboplatin (without diaplatin) with Navelbine , or taxol , or ALIMTA ... cal + D, Vitamidyne DRP 200IU, Konsyl orange, oxycontin, Carboplatin, Navelbine, taxol, ALIMTA, Erbitux, Avastin, Vinorelbine, ...
antagonists Calcium tablets Carbon cage Carboplatin Carboplatinum Cardiological therapy Cardioversion ...
(cyclophosphamide) 4 g/m 2 CBDCA 1 (carboplatin) 800 mg/m 2 VCR (vincristine) 1.5 mg/m 2 ...
chemotherapeutic option could be again platin-based and carboplatin should be preferred, either in combination with gemcitabin ...
( 2) Would the SIOP induction carboplatin/vincristine chemotherapy be the correct plan if treatment is ... optic gliomas in all children under age 10 years is carboplatin/vincristine . Other chemotherapeutics have been used, but in ...
and 7.06 the first cycle of chemotherapy (cycle A) with Carboplatin, Vincristine and Etoposide has been administered. The therapy has ... Medicines : TOBRAL eye drops, induction chemotherapy, Carboplatin, Vincristine, Etoposide, Bactrim, Zofran syrup, Paxabel, parenteral ...
using four courses of chemotherapy with paclitaxel, carboplatin, and etoposide , administered at 3-week intervals followed by ... DR, Litchy S, Greco FA.Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine ...
can you comment on the difference between these options? (Carboplatin (without diaplatin) with Navelbine, or taxol, or ALIMTA / Weekly ... , Dr. G. recommended chemotherapy treatment as follows: Carboplatin (without diaplatin) with Navelbine , or taxol , or ALIMTA ...
adenocarcinoma. He is currently receiving therapy with carboplatin plus pemetrexed. Based on the information provided thus far, I ... exclude presence of CNS disease. 2. Current therapy (carboplatin plus pemetrexed): - If tolerating without significant toxicity, ...